213 related articles for article (PubMed ID: 36541064)
1. Evaluation of metagenomic next-generation sequencing diagnosis for invasive pulmonary aspergillosis in immunocompromised and immunocompetent patients.
Zhan W; Liu Q; Yang C; Zhao Z; Yang L; Wang Y; Feng J
Mycoses; 2023 Apr; 66(4):331-337. PubMed ID: 36541064
[TBL] [Abstract][Full Text] [Related]
2. Metagenomic next-generation sequencing for detecting
Shi Y; Peng JM; Hu XY; Yang QW; Wang Y
Front Cell Infect Microbiol; 2023; 13():1209724. PubMed ID: 38188627
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic efficacy of metagenomic next generation sequencing in bronchoalveolar lavage fluid for proven invasive pulmonary aspergillosis.
Jia H; Liu H; Tu M; Wang Y; Wang X; Li J; Zhang G
Front Cell Infect Microbiol; 2023; 13():1223576. PubMed ID: 37692168
[TBL] [Abstract][Full Text] [Related]
4. Performance of mNGS in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients.
Zhu N; Zhou D; Xiong W; Zhang X; Li S
Front Cell Infect Microbiol; 2023; 13():1271853. PubMed ID: 38029249
[TBL] [Abstract][Full Text] [Related]
5. Metagenomic next-generation sequencing for the diagnosis of pulmonary aspergillosis in non-neutropenic patients: a retrospective study.
Bao S; Song H; Chen Y; Zhong C; Tang H
Front Cell Infect Microbiol; 2022; 12():925982. PubMed ID: 35979088
[TBL] [Abstract][Full Text] [Related]
6. Invasive Pulmonary Aspergillosis Diagnosis
Ma X; Zhang S; Xing H; Li H; Chen J; Li H; Jiao M; Shi Q; Xu A; Xing L; Cao W
Front Med (Lausanne); 2022; 9():751617. PubMed ID: 35402461
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients.
Ao Z; Xu H; Li M; Liu H; Deng M; Liu Y
BMJ Open Respir Res; 2023 Feb; 10(1):. PubMed ID: 36828645
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different criteria of metagenomic next-generation sequencing for the diagnosis of invasive pulmonary aspergillosis in critically ill patients.
Liu RT; Zhang D; Li S; Chen Y; Wan XX; Diao ST; Weng L; Peng JM; Du B
Diagn Microbiol Infect Dis; 2024 Feb; 108(2):116135. PubMed ID: 38065016
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients.
Lin P; Chen Y; Su S; Nan W; Zhou L; Zhou Y; Li Y
BMC Infect Dis; 2022 Apr; 22(1):416. PubMed ID: 35488253
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis by metagenomic next-generation sequencing of invasive pulmonary aspergillosis in an infant with chronic granulomatous disease.
Yang A; Wang C; Chen P; Zheng G; Zhao Z; Liu J; Zhang J; Wang J; Sun Y; Yang J; Guo Y
Respir Med Case Rep; 2023; 41():101792. PubMed ID: 36568318
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of metagenomic next-generation sequencing for cryptococcosis in immunocompetent and immunocompromised patients.
Su Y; Miao Q; Li N; Hu BJ; Pan J
Front Cell Infect Microbiol; 2022; 12():997256. PubMed ID: 36339336
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
14. Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients.
Peng JM; Du B; Qin HY; Wang Q; Shi Y
J Infect; 2021 Apr; 82(4):22-27. PubMed ID: 33609588
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
[TBL] [Abstract][Full Text] [Related]
16. Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients.
Mikulska M; Furfaro E; Dettori S; Giacobbe DR; Magnasco L; Dentone C; Ball L; Russo C; Taramasso L; Vena A; Angelucci E; Pelosi P; Bassetti M
Mycoses; 2022 Apr; 65(4):411-418. PubMed ID: 35138675
[TBL] [Abstract][Full Text] [Related]
17. Cellular analysis and metagenomic next-generation sequencing of bronchoalveolar lavage fluid in the distinction between pulmonary non-infectious and infectious disease.
Pan Y; Zhang X; Sun Y; Zhang Y; Bao W; Yin D; Zhang P; Zhang M
Front Cell Infect Microbiol; 2022; 12():1023978. PubMed ID: 36760236
[TBL] [Abstract][Full Text] [Related]
18. Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: a prospective study in pediatric patients.
Mohammadi S; Khalilzadeh S; Goudarzipour K; Hassanzad M; Mahdaviani A; Aarabi N; Pourabdollah M; Sigari N
Med Mycol; 2015 Sep; 53(7):709-16. PubMed ID: 26229150
[TBL] [Abstract][Full Text] [Related]
19. Improving pulmonary infection diagnosis with metagenomic next-generation sequencing of bronchoalveolar lavage fluid.
Long Y; Xia X; Feng H; Zhao P
J Med Microbiol; 2024 Feb; 73(2):. PubMed ID: 38420890
[No Abstract] [Full Text] [Related]
20. [The application value of metagenomic next-generation sequencing technology in diagnosis and treatment of pulmonary infection in immunocompromised patients].
Duan ZM; Shen ZY; Hu Y; Wang KF; Fu H; Wang CL; Xie LX; Xie F
Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(25):1885-1891. PubMed ID: 37402668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
